Board Review Questions

Transfusion Reactions (part 2)



A new era of TTP treatment

Many questions remain following the FDA’s approval of caplacizumab, specifically, which patients should receive it. The high cost of the drug is...

Conference Coverage

Repeat VTE risk heightened in HIV patients

SEATTLE – Two studies detail the risk factors of first-time venous thromboembolism and heightened incidence of repeat VTE in patients with HIV.

Board Review Questions

Transfusion Reactions (part 1)

From the Journals

Coagulation pathway may play role in IBD

Increased activity of a gene associated with the coagulation pathway is linked to more severe inflammatory bowel disease and treatment nonresponse...